These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12948367)

  • 41. [Immunization of adults against varicella and herpes zoster].
    Hanslik T; Blanchon T; Alvarez FP
    Rev Med Interne; 2007 Mar; 28(3):166-72. PubMed ID: 17270316
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia.
    Gidding HF; Brisson M; Macintyre CR; Burgess MA
    Aust N Z J Public Health; 2005 Dec; 29(6):544-51. PubMed ID: 16366065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Twenty Years of Medically-Attended Pediatric Varicella and Herpes Zoster in Ontario, Canada: A Population-Based Study.
    Wormsbecker AE; Wang J; Rosella LC; Kwong JC; Seo CY; Crowcroft NS; Deeks SL
    PLoS One; 2015; 10(7):e0129483. PubMed ID: 26177077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.
    Edgar BL; Galanis E; Kay C; Skowronski D; Naus M; Patrick D
    Can Commun Dis Rep; 2007 Nov; 33(11):1-15. PubMed ID: 18163240
    [No Abstract]   [Full Text] [Related]  

  • 45. Universal varicella vaccination increased the incidence of herpes zoster in the child-rearing generation as its short-term effect.
    Toyama N; Shiraki K;
    J Dermatol Sci; 2018 Oct; 92(1):89-96. PubMed ID: 30041832
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Universal varicella vaccination: efficacy trends and effect on herpes zoster.
    Goldman GS
    Int J Toxicol; 2005; 24(4):205-13. PubMed ID: 16126614
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing incidence associated with herpes zoster infection in British Columbia, Canada.
    Marra F; Chong M; Najafzadeh M
    BMC Infect Dis; 2016 Oct; 16(1):589. PubMed ID: 27765026
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Varicella-zoster virus infection in Australia.
    Chant KG; Sullivan EA; Burgess MA; Ferson MJ; Forrest JM; Baird LM; Tudehope DI; Tilse M
    Aust N Z J Public Health; 1998 Jun; 22(4):413-8. PubMed ID: 9659764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study.
    Marziano V; Poletti P; Guzzetta G; Ajelli M; Manfredi P; Merler S
    Proc Biol Sci; 2015 Apr; 282(1804):20142509. PubMed ID: 25761709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Varicella vaccination in Australia.
    Macartney KK; Beutels P; McIntyre P; Burgess MA
    J Paediatr Child Health; 2005 Nov; 41(11):544-52. PubMed ID: 16398834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings.
    Viner K; Perella D; Lopez A; Bialek S; Newbern C; Pierre R; Spells N; Watson B
    J Infect Dis; 2012 May; 205(9):1336-41. PubMed ID: 22454467
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
    Horn J; Damm O; Greiner W; Hengel H; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Karch A; Mikolajczyk RT
    BMC Med; 2018 Jan; 16(1):3. PubMed ID: 29316913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany.
    Siedler A; Dettmann M
    Hum Vaccin Immunother; 2014; 10(12):3594-600. PubMed ID: 25483695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.
    Gao Z; Wood JG; Gidding HF; Newall AT; Menzies RI; Wang H; McIntyre PB; MacIntyre CR
    Epidemiol Infect; 2015 May; 143(7):1467-76. PubMed ID: 25222565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination.
    Civen R; Chaves SS; Jumaan A; Wu H; Mascola L; Gargiullo P; Seward JF
    Pediatr Infect Dis J; 2009 Nov; 28(11):954-9. PubMed ID: 19536039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Varicella vaccination in England and Wales: cost-utility analysis.
    Brisson M; Edmunds WJ
    Arch Dis Child; 2003 Oct; 88(10):862-9. PubMed ID: 14500303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000-2008.
    Chao DY; Chien YZ; Yeh YP; Hsu PS; Lian IB
    Epidemiol Infect; 2012 Jun; 140(6):1131-40. PubMed ID: 21906410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
    Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
    Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program.
    Tanuseputro P; Zagorski B; Chan KJ; Kwong JC
    Vaccine; 2011 Nov; 29(47):8580-4. PubMed ID: 21939721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.